A carregar...
ECRG2 enhances the anti-cancer effects of cisplatin in cisplatin-resistant esophageal cancer cells via upregulation of p53 and downregulation of PCNA
AIM: To explore the anti-tumor effects of esophageal cancer-related gene 2 (ECRG2) in combination with cisplatin (DDP) in DDP-resistant esophageal cancer cells (EC9706/DDP). METHODS: A drug-resistant cell model was established, with EC9706/DDP cells being treated with ECRG2 and/or DDP. Cell viabilit...
Na minha lista:
| Publicado no: | World J Gastroenterol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Baishideng Publishing Group Inc
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5352920/ https://ncbi.nlm.nih.gov/pubmed/28348485 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v23.i10.1796 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|